Since the first publication of the derivation of human embryonic stem cells in 1998, there has been hope and requirement that this technology will lead to a wave of regenerative medication therapies with the potential to revolutionize our approach to managing certain diseases. to reduction of RPE. Delivery of RPE cells (or certainly various other… Continue reading Since the first publication of the derivation of human embryonic stem